<DOC>
	<DOCNO>NCT02523183</DOCNO>
	<brief_summary>Many family child medically refractory epilepsy choose use medicinal cannabinoids ( MCBD ) adjunctive alternative treatment option . The safety , tolerability efficacy product know . The primary objective study determine use MCBD affect child medically refractory epilepsy observational study . Measures evaluation use include : laboratory value , developmental measure , seizure diary serial electroencephalographic ( EEG ) recording .</brief_summary>
	<brief_title>The Use Medicinal Cannabinoids Adjunctive Treatment Medically Refractory Epilepsy</brief_title>
	<detailed_description>This observational study family 's choice use MCBD effect substance medically refractory epilepsy child . The risk associate use well know . There recently report stroke , liver dysfunction alter anticonvulsant level . In addition , long term risk report decreased memory function , cognitive problem executive function abnormality . This study condone advocate use substance merely seek document short term effect use population . It note provider Children 's Hospital Colorado register provider medicinal cannabis ; therefore , observational study effect substance prescribe physician outside institution .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<criteria>1 . Male Female &gt; 1 month age 2 . Documentation diagnosis medically refractory epilepsy evidence medical record , genetic test and/or follow clinical feature : Failure control seizures despite appropriate trial two anticonvulsant medication therapeutic dos 3 . Baseline seizure frequency least 2 per week follow type : Generalized tonicclonic Clonic Tonic Hemiconvulsive Drop attack Focal motor Epileptic spasms 4 . 13 baseline antiseizure medication stable dos minimum 4 week prior enrollment . 5 . Written inform consent obtain patient patient 's legal representative . 1 . Epilepsies associate rapidly progress neurodegenerative disease ex : Rasmussen encephalitis , tumor . 2 . Epilepsies associate treatable inborn error metabolism 3 . Presence condition abnormality opinion Investigator would compromise safety patient quality data . 4 . Nonepileptic event . 5 . Current use MCBD product ( Note : Patient eligible currently use MCBD switch different product ) .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Marijuana</keyword>
</DOC>